Study S002395

GIP/GLP-1 Co-Activity in Subjects With Overweight and Type 2 Diabetes: Lowering of Food Intake

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03526289
Acronym: GASOLIN II
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: DOUBLE
Status: COMPLETED
Enrollment: 22
Start: 2017-11-08
Primary completion: 2018-10-24
Lead sponsor: University Hospital, Gentofte, Copenhagen
Conditions: Type 2 Diabetes Mellitus; Overweight and Obesity
Interventions: BIOLOGICAL:GIP1-42 infusion; OTHER:Saline
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

food intake [time point 300-330 minutes]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0010730	No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 Diabetes. Bergmann NC, Diabetes care	2020	Randomized trial	PMID 31949084 DOI	cites ClinicalTrials.gov:NCT03526289; registry reference DERIVED:31949084